基本信息
浏览量:3
职业迁徙
个人简介
I am involved in clinical research at the phase I, II and III levels on the therapy of chronic myeloid leukemia. This involves targeted therapy with kinase inhibitors, drugs that may target the CML stem cell and cells that are resistant to other therapies. The interest in targeted therapy extends into the phase II study of signal transduction inhibitors in the therapy of other diseases such as systemic mastocytosis and mast cell leukemia.
The second aspect of my clinical research involves outcome analysis in allogeneic stem cell transplant and the prevention and therapy of side effects. I am particularly interested in donor selection, graft types and therapy of chronic side effects. I am also interested in long term effects on patients who are out beyond the initial post transplant period.
The second aspect of my clinical research involves outcome analysis in allogeneic stem cell transplant and the prevention and therapy of side effects. I am particularly interested in donor selection, graft types and therapy of chronic side effects. I am also interested in long term effects on patients who are out beyond the initial post transplant period.
研究兴趣
论文共 159 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CURRENT ONCOLOGYno. 3 (2024): 1246-1252
Clinical Drug Investigationno. 2 (2024): 91-108
EUROPEAN JOURNAL OF HAEMATOLOGYno. 3 (2024): 433-438
Tommy Alfaro Moya,Maria Queralt Salas, Abel Santos Carreira,Eshetu G. Atenafu,Arjun Datt Law,Wilson Lam,Ivan Pasic,Dennis (Dong Hwan) Kim,Fotios V. Michelis, Igor Novitzky Basso,Armin Gerbitz,Jeffrey Howard Lipton,
Clinical Lymphoma Myeloma and Leukemia (2024)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023): S527-S527
Transplantation and cellular therapyno. 12 (2023): 773.e1-773.e10
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn